More data supporting the cardio protective effect of GLP-1 targeted therapy (this time Tirzepatide led to a lower risk of death from cardiovascular causes or worsening heart failure than placebo https://www.nejm.org/doi/full/10.1056/NEJMoa2410027
Comments
Log in with your Bluesky account to leave a comment
Comments